Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways

References

• Crabtree, G.R., Clipstone, N.A. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 1994, 63, 1045–1083.
   PubMed Web of Science ®Google Scholar
• Karin, M., Ben-Neriah, Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu Rev Immunol 2000, 18, 621–663.
   PubMed Web of Science ®Google Scholar
• Vermeulen, L., De Wilde, G., Notebaert, S., Vanden Berghe, W., Haegeman, G. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem Pharmacol 2002, 64, 963–970.
   PubMed Web of Science ®Google Scholar
• Hogan, P.G., Chen, L., Nardone, J., Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003, 17, 2205–2232.
   PubMed Web of Science ®Google Scholar
• Macián, F., López-Rodríguez, C., Rao, A. Partners in transcription: NFAT and AP-1. Oncogene 2001, 20, 2476–2489.
   PubMed Web of Science ®Google Scholar
• Hagemann, C., Blank, J.L. The ups and downs of MEK kinase interactions. Cell Signal 2001, 13, 863–875.
   PubMed Web of Science ®Google Scholar
• Kiani, A., Rao, A., Aramburu, J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000, 12, 359–372.
   PubMed Web of Science ®Google Scholar
• Tian, B., Brasier, A.R. Identification of a nuclear factor κB-dependent gene network. Recent Prog Horm Res 2003, 58, 95–130.
   PubMedGoogle Scholar
• de Gregorio, R., Iñiguez, M.A., Fresno, M., Alemany, S. Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells. J Biol Chem 2001, 276, 27003–27009.
   PubMed Web of Science ®Google Scholar
• Ho, I.C., Kim, J.I., Szabo, S.J., Glimcher, L.H. Tissue-specific regulation of cytokine gene expression. Cold Spring Harb Symp Quant Biol 1999, 64, 573–584.
   PubMedGoogle Scholar
• Gaffen, S.L., Liu, K.D. Overview of interleukin-2 function, production and clinical applications. Cytokine 2004, 28, 109–123.
   PubMed Web of Science ®Google Scholar
• Williams, M.A., Tyznik, A.J., Bevan, M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006, 441, 890–893.
   PubMed Web of Science ®Google Scholar
• Hoyer, K.K., Dooms, H., Barron, L., Abbas, A.K. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008, 226, 19–28.
   PubMed Web of Science ®Google Scholar
• Baud, V., Karin, M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001, 11, 372–377.
   PubMed Web of Science ®Google Scholar
• Wajant, H., Pfizenmaier, K., Scheurich, P. Tumor necrosis factor signaling. Cell Death Differ 2003, 10, 45–65.
   PubMed Web of Science ®Google Scholar
• Yano, O., Kanellopoulos, J., Kieran, M., Le Bail, O., Israël, A., Kourilsky, P. Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J 1987, 6, 3317–3324.
   PubMed Web of Science ®Google Scholar
• Durand, D.B., Shaw, J.P., Bush, M.R., Replogle, R.E., Belagaje, R., Crabtree, G.R. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol 1988, 8, 1715–1724.
   PubMed Web of Science ®Google Scholar
• Luo, C., Burgeon, E., Rao, A. Mechanisms of transactivation by nuclear factor of activated T cells-1. J Exp Med 1996, 184, 141–147.
   PubMed Web of Science ®Google Scholar
• Schmitz, M.L., dos Santos Silva, M.A., Baeuerle, P.A. Transactivation domain 2 (TA2) of p65 NF-κB. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells. J Biol Chem 1995, 270, 15576–15584.
   PubMed Web of Science ®Google Scholar
• Sancho, R., Lucena, C., Macho, A., Calzado, M.A., Blanco-Molina, M., Minassi, A., Appendino, G., Muñoz, E. Immunosuppressive activity of capsaicinoids: Capsiate derived from sweet peppers inhibits NF-κB activation and is a potent antiinflammatory compound in vivo. Eur J Immunol 2002, 32, 1753–1763.
   PubMed Web of Science ®Google Scholar
• Spriggs, D.R., Deutsch, S., Kufe, D.W. Genomic structure, induction, and production of TNF-alpha. Immunol Ser 1992, 56, 3–34.
   PubMedGoogle Scholar
• Truneh, A., Albert, F., Golstein, P., Schmitt-Verhulst, A.M. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 1985, 313, 318–320.
   PubMed Web of Science ®Google Scholar
• Ma, G., Bavadekar, S.A., Davis, Y.M., Lalchandani, S.G., Nagmani, R., Schaneberg, B.T., Khan, I.A., Feller, D.R. Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)-adrenergic receptor subtypes. J Pharmacol Exp Ther 2007, 322, 214–221.
   PubMed Web of Science ®Google Scholar
• Vansal, S.S., Feller, D.R. Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol 1999, 58, 807–810.
   PubMed Web of Science ®Google Scholar
• Empey, D.W., Young, G.A., Letley, E., John, G.C., Smith, P., McDonnell, K.A., Bagg, L.R., Hughes, D.T. Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol 1980, 9, 351–358.
   PubMed Web of Science ®Google Scholar
• Jawad, S.S., Eccles, R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998, 36, 73–76.
   PubMedGoogle Scholar
• Eccles, R., Jawad, M.S., Jawad, S.S., Angello, J.T., Druce, H.M. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol 2005, 19, 25–31.
   PubMedGoogle Scholar
• Loose, I., Winkel, M. Clinical, double-blind, placebo-controlled study investigating the combination of acetylsalicylic acid and pseudoephedrine for the symptomatic treatment of nasal congestion associated with common cold. Arzneimittelforschung 2004, 54, 513–521.
   PubMed Web of Science ®Google Scholar
• Schachtel, B.P., Voelker, M., Sanner, K.M., Gagney, D., Bey, M., Schachtel, E.J., Becka, M. Demonstration of the analgesic efficacy and dose-response of acetylsalicylic acid with pseudoephedrine. J Clin Pharmacol 2010, 50, 1429–1437.
   PubMed Web of Science ®Google Scholar
• Roman, M.C. Determination of ephedra alkaloids in urine and plasma by HPLC-UV: Collaborative study. J AOAC Int 2004, 87, 15–24.
   PubMed Web of Science ®Google Scholar
• Deventer, K., Van Eenoo, P., Baele, G., Pozo, O.J., Van Thuyne, W., Delbeke, F.T. Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. Drug Test Anal 2009, 1, 209–213.
   PubMed Web of Science ®Google Scholar
• Luqman, W., Danowski, T.S. The use of khat (Catha edulis) in Yemen. Social and medical observations. Ann Intern Med 1976, 85, 246–249.
   PubMed Web of Science ®Google Scholar
• Hoffman, R., Al’’Absi, M. Khat use and neurobehavioral functions: Suggestions for future studies. J Ethnopharmacol 2010, 132, 554–563.
   PubMed Web of Science ®Google Scholar
• Lin, X., Cunningham, E.T. Jr, Mu, Y., Geleziunas, R., Greene, W.C. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 1999, 10, 271–280.
   PubMed Web of Science ®Google Scholar
• Chiariello, M., Marinissen, M.J., Gutkind, J.S. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-Jun promoter and to cellular transformation. Mol Cell Biol 2000, 20, 1747–1758.
   PubMed Web of Science ®Google Scholar
• Sakurai, H., Chiba, H., Miyoshi, H., Sugita, T., Toriumi, W. IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999, 274, 30353–30356.
   PubMed Web of Science ®Google Scholar
• O’’Mahony, A.M., Montano, M., Van Beneden, K., Chen, L.F., Greene, W.C. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-κB requires IκB kinase-1-mediated phosphorylation of RelA/p65. J Biol Chem 2004, 279, 18137–18145.
   PubMed Web of Science ®Google Scholar
• Jiang, X., Takahashi, N., Matsui, N., Tetsuka, T., Okamoto, T. The NF-κB activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J Biol Chem 2003, 278, 919–926.
   PubMed Web of Science ®Google Scholar
• Buss, H., Dörrie, A., Schmitz, M.L., Hoffmann, E., Resch, K., Kracht, M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 2004, 279, 55633–55643.
   PubMed Web of Science ®Google Scholar
• Adli, M., Baldwin, A.S. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem 2006, 281, 26976–26984.
   PubMed Web of Science ®Google Scholar
• Schmitz, M.L., Bacher, S., Kracht, M. IκB-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem Sci 2001, 26, 186–190.
   PubMed Web of Science ®Google Scholar
• Molkentin, J.D. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 2004, 63, 467–475.
   PubMed Web of Science ®Google Scholar
• Szabo, S.J., Gold, J.S., Murphy, T.L., Murphy, K.M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: Roles for NF-Y and NF-ATc. Mol Cell Biol 1993, 13, 4793–4805.
   PubMed Web of Science ®Google Scholar
• Takemoto, N., Koyano-Nakagawa, N., Arai, N., Arai, K., Yokota, T. Four P-like elements are required for optimal transcription of the mouse IL-4 gene: Involvement of a distinct set of nuclear factor of activated T cells and activator protein-1 family proteins. Int Immunol 1997, 9, 1329–1338.
   PubMed Web of Science ®Google Scholar
• Lyakh, L., Ghosh, P., Rice, N.R. Expression of NFAT-family proteins in normal human T cells. Mol Cell Biol 1997, 17, 2475–2484.
   PubMed Web of Science ®Google Scholar
• Rooney, J.W., Hoey, T., Glimcher, L.H. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995, 2, 473–483.
   PubMed Web of Science ®Google Scholar
• Li-Weber, M., Giaisi, M., Baumann, S., Pálfi, K., Krammer, P.H. NF-κB synergizes with NF-AT and NF-IL6 in activation of the IL-4 gene in T cells. Eur J Immunol 2004, 34, 1111–1118.
   PubMed Web of Science ®Google Scholar